Arteris, Inc. (NASDAQ:AIP) CEO Sells $631,285.28 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 60,584 shares of the business’s stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $10.42, for a total transaction of $631,285.28. Following the completion of the sale, the chief executive officer now directly owns 10,134,541 shares in the company, valued at $105,601,917.22. This trade represents a 0.59 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

K Charles Janac also recently made the following trade(s):

• On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total transaction of $141,941.80.
• On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72.
• On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total value of $10,656.36.
• On Wednesday, October 2nd, K Charles Janac sold 5,520 shares of Arteris stock. The stock was sold at an average price of $7.18, for a total value of $39,633.60.

Arteris Stock Performance

NASDAQ:AIP opened at $10.19 on Thursday. The stock has a market capitalization of $409.40 million, a P/E ratio of -10.61 and a beta of 1.25. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. Arteris, Inc. has a 1 year low of $4.83 and a 1 year high of $10.69. The firm has a 50 day moving average of $8.69 and a 200-day moving average of $8.00.

Hedge Funds Weigh In On Arteris

A number of institutional investors and hedge funds have recently bought and sold shares of the business. US Bancorp DE acquired a new position in shares of Arteris during the third quarter worth approximately $34,000. The Manufacturers Life Insurance Company bought a new position in Arteris in the 2nd quarter worth approximately $86,000. Algert Global LLC acquired a new position in Arteris during the 2nd quarter worth $115,000. MetLife Investment Management LLC boosted its position in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Arteris in the 3rd quarter valued at $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Analyst Ratings Changes

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price objective on shares of Arteris in a research note on Wednesday, November 6th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.